Cuu Long Pharmaceutical JSC (HOSE: DCL)

Market Cap	1.94T
Revenue (ttm)	1.19T
Net Income (ttm)	63.49B
Shares Out	73.04M
EPS (ttm)	869.24
PE Ratio	30.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,800
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	22,600 - 32,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 24, 2025

About HOSE: DCL

Cuu Long Pharmaceutical Joint Stock Company manufactures and distributes pharmaceutical products primarily in Vietnam. The company offers analgesic, anti-biotic, anti-histamine, anti-inflammatory, anti-virus, cardiovascular, corticosteroid, cough, dermatology, gastrointestinal, musculoskeletal, and vitamin medicines, as well as capsules and medical equipment. It provides its products under various brands to hospitals through its distribution network, including branches and distributors. The company was founded in 1976 and is headquartered in Vi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 930
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2023, DCL's revenue was 1.14 trillion, an increase of 12.63% compared to the previous year's 1.02 trillion. Earnings were 61.72 billion, a decrease of -43.19%.